SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin gets additional time to set up unit at Nagpur SEZ

19 May 2015 Evaluate

Pharma major Lupin has been granted an extension to set up its state-of-the-art formulation manufacturing unit at the MIHAN Special Economic Zone (SEZ) in Nagpur from the Commerce Ministry. However, a final call on the matter is yet to be taken by the Board of Approval (BoA) for SEZs.

Lupin had sought the extension on the grounds that it is yet to receive approvals from the US Food and Drug Administration (USFDA) for drugs that are to be produced at the unit. The company received the letter-of-permission (LoP) for setting up its unit in the MIHAN SEZ in April 2012, but has not been able to start commercial operations.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.

Lupin Share Price

2245.65 -132.25 (-5.56%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×